Stay updated on FF-10101-01 Study in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.

Latest updates to the FF-10101-01 Study in Relapsed AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home option, replacing the previously visible study details with an access-block message.SummaryDifference21%

- Check20 days agoChange DetectedThe page shows a revision update from v3.6.6 to v3.7.0, indicating a new release of the page or platform. This update seems to affect the UI/versioning rather than the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a maintenance update. The visible content and user experience appear unchanged.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, representing a small behind-the-scenes update to the page version.SummaryDifference0.0%

- Check70 days agoChange DetectedThe revision history shows that v3.6.4 was added and the previous v3.6.3 was removed, updating the site's version tag.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, indicating a minor update to the document version.SummaryDifference0.0%

Stay in the know with updates to FF-10101-01 Study in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.